TY - JOUR
T1 - Sentinel node mapping for post-endoscopic resection gastric cancer
T2 - multicenter retrospective cohort study in Japan
AU - Japanese Society for Sentinel Node Navigation Surgery
AU - Mayanagi, Shuhei
AU - Takahashi, Naoto
AU - Mitsumori, Norio
AU - Arigami, Takaaki
AU - Natsugoe, Shoji
AU - Yaguchi, Yoshihisa
AU - Suda, Takeshi
AU - Kinami, Shinichi
AU - Ohi, Masaki
AU - Kawakubo, Hirofumi
AU - Sato, Yasunori
AU - Takeuchi, Hiroya
AU - Aikou, Takashi
AU - Kitagawa, Yuko
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Background: Standard gastrectomy with systematic lymphadenectomy as an additional surgery after endoscopic resection (ER) causes a deterioration in long-term quality of life. If the sentinel lymph node (SN) basin concept can be applied in post-ER gastric cancer, minimal surgery can be applied without reducing the curability. This retrospective multicenter cohort study aimed to verify the validity of the SN basin concept in post-ER gastric cancer. Patients and methods: Individual data of 132 patients who underwent SN mapping after ER were collected from 8 university hospitals in Japan from 2001 to 2016. Tracers were injected endoscopically in the submucosal layer at four sites around the post-ER scar. We compared the SN basin distribution of post-ER gastric cancer with that of 275 patients with non-ER gastric cancer. Results: Two cases of SN were unidentified, both involving a single tracer (SN detection rate: 98.5%). Nine cases (6.8%) of lymph node metastasis were found, of which eight had a metastatic lymph node within the SNs and one had a non-SN metastasis within the SN basin. The diagnostic sensitivity of SN mapping for lymph node metastasis was 88.9% in post-ER group and 95.7% in non-ER group (P = 0.490); the accuracy was 99.2% and 99.6% (P = 0.539), respectively. Regarding the SN basin, no significant intergroup differences were found regardless of the primary tumor location. Conclusions: Our findings clarified the feasibility of SN mapping based on the SN basin concept in patients with gastric cancer who previously underwent ER.
AB - Background: Standard gastrectomy with systematic lymphadenectomy as an additional surgery after endoscopic resection (ER) causes a deterioration in long-term quality of life. If the sentinel lymph node (SN) basin concept can be applied in post-ER gastric cancer, minimal surgery can be applied without reducing the curability. This retrospective multicenter cohort study aimed to verify the validity of the SN basin concept in post-ER gastric cancer. Patients and methods: Individual data of 132 patients who underwent SN mapping after ER were collected from 8 university hospitals in Japan from 2001 to 2016. Tracers were injected endoscopically in the submucosal layer at four sites around the post-ER scar. We compared the SN basin distribution of post-ER gastric cancer with that of 275 patients with non-ER gastric cancer. Results: Two cases of SN were unidentified, both involving a single tracer (SN detection rate: 98.5%). Nine cases (6.8%) of lymph node metastasis were found, of which eight had a metastatic lymph node within the SNs and one had a non-SN metastasis within the SN basin. The diagnostic sensitivity of SN mapping for lymph node metastasis was 88.9% in post-ER group and 95.7% in non-ER group (P = 0.490); the accuracy was 99.2% and 99.6% (P = 0.539), respectively. Regarding the SN basin, no significant intergroup differences were found regardless of the primary tumor location. Conclusions: Our findings clarified the feasibility of SN mapping based on the SN basin concept in patients with gastric cancer who previously underwent ER.
KW - Early gastric cancer
KW - Endoscopic mucosal resection
KW - Endoscopic submucosal dissection
KW - Sentinel lymph node
UR - http://www.scopus.com/inward/record.url?scp=85078595924&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078595924&partnerID=8YFLogxK
U2 - 10.1007/s10120-019-01038-3
DO - 10.1007/s10120-019-01038-3
M3 - Article
C2 - 31927674
AN - SCOPUS:85078595924
SN - 1436-3291
VL - 23
SP - 716
EP - 724
JO - Gastric Cancer
JF - Gastric Cancer
IS - 4
ER -